HRS-9813

· Guangdong Hengrui Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HRS-9813, covering 2025-01-08 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis [Phase 2]

See pricing